![MAIA Biotechnology, Inc.](https://parsers.vc/logo/ac71d011-431d-49ab-a38f-7a43b69de6c3-4.jpg)
MAIA Biotechnology is a targeted therapy, immune-oncology company, focused on development and commercialization of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer.
A privately-held company based in Chicago, MAIA is led by a passionate, principled and highly experienced Management Team with significant drug development experience, committed to advancing promising agents into trials in humans clinical trials.
MAIA’s business strategy is designed to advance a strong value proposition for its portfolio of potentially novel compounds. MAIA controls risk and enhances its opportunity for success by diversifying and generating this portfolio of assets with a variety of compounds with novel mechanisms of action which have potential activity in multiple tumor types.
MAIA’s business model involves placing drug candidates in their own dedicated, R&D focused subsidiary company, which is supported by the common infrastructure, management team, and resources of the MAIA enterprise. This model allows MAIA to provide more focused R&D support to each drug candidate, while also distributing shared central resources among subsidiary companies to maintain a lean, capital-efficient operating structure.
Location: United States, Illinois, Chicago
Member count: 11-50
Total raised: $8M
Founded date: 2018
Investors 1
Date | Name | Website |
- | Checkmate ... | checkmatec... |
Funding Rounds 1
Date | Series | Amount | Investors | Deal News |
19.05.2021 | - | $8M | - | marketscre... |
Mentions in press and media 3
Date | Title | Description | Category | Author | Source |
14.10.2021 | MAIA Biote... | MAIA Biotechnology, Inc., a ta... | - | - | marketscre... |
19.05.2021 | Maia Biote... | Maia Biotechnology, Inc., a Ch... | USA | - | finsmes.co... |
19.05.2021 | MAIA Biote... | MAIA Biotechnology, Inc., a ta... | - | - | marketscre... |